Former subsidiary of the Roche Group operating the largest production site for sterile ampoules in Europe, Cenexi became an independent company in 2008. The company acquired two new production sites in Osny in France and in Braine l’Alleud in Belgium, respectively specialized in solid forms of hormonal and anti-allergy products and injectable oncologic products. Cenexi has also developed an offering of complementary services, including formulation, analytical development, product portfolio transfer management and regulatory support. These developments have allowed the company to enhance its client base, which today includes over 80 clients, and which mainly consists of international pharmaceutical groups, both generalist and specialist entities. Leveraging its solid industrial know-how and its operational excellence, all of Cenexi’s sites are registered with major world health authorities (FDA, Japan, China…), which allows the group to distribute its products in over 150 countries.
Location: Metropolitan France
Employees: 1001-5000
Founded date: 2004
Investors 2
| Date | Name | Website |
| - | Cathay Cap... | cathaycapi... |
| - | Invest.BW | investbw.b... |
Mentions in press and media 5
| Date | Title | Description |
| 03.02.2025 | Gland Pharma and Equirus: Navigating Challenges and Opportunities in a Shifting Landscape | In the bustling world of pharmaceuticals and finance, two companies are making headlines: Gland Pharma and Equirus. Each is navigating its own set of challenges and opportunities, reflecting the dynamic nature of their respective industries... |
| 03.02.2025 | Gland Pharma Q3 net up 7% at ₹205 crore | Gland Pharma’s consolidated net profit increased 7 per cent at ₹205 crore in the third quarter ended December 2024 compared to ₹192 crore in the corresponding quarter of previous financial year. The total revenue of the Hyderabad based comp... |
| 16.05.2024 | Fosun attends "Choose France" Summit for a third time | HONG KONG, May 16, 2024 /PRNewswire/ -- On 13 May 2024, Guo Guangchang, Chairman of Fosun International, attended the Choose France Summit hosted by the French government in Paris. During the summit, Guo Guangchang engaged in discussions wi... |
| 29.11.2022 | Gland Pharma to acquire Cenexi group at an equity value of €120 m | Gland Pharma, through its arm Gland Pharma International PTE. Ltd, Singapore, entered into a put option agreement to acquire France-based Cenexi Group for an equity value not exceeding €120 million (enterprise value of €230 million). “This ... |
| 30.06.2021 | OSE Immunotherapeutics Announces Manufacturing Agreement with Cenexi for Clinical Batches of CoVepiT, OSE's Multi-Target Second-Generation COVID-19 Vaccine | NANTES, France and FONTENAY-SOUS-BOIS, France, June 30, 2021 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnemo: OSE) and Cenexi, a French contract development and manufacturing organization (CDMO), today announced the si... |